Clinical Trial Update: The Effect on Lipid Profile of Switching to Delstrigo in HIV Positive Patients [Phase 4]

View source ↗

Summary

This Phase 4 study evaluates the effect on lipid profile when HIV-positive patients switch to Delstrigo. The trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DELSTRIGO (DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: Hiv | Phase 4 | Status: TERMINATED